Respirerx Pharmaceuticals Inc (RSPI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RSPI Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Respirerx Pharmaceuticals Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Deferred Costs, Current AS0.01
Other Current Assets0.05
Prepaid Expense, Current AS0.08
Total Current Assets0.14
Other Assets, Noncurrent0.00
Total Assets0.14
Liabilities
Accounts Payable, Current AC5.89
Employee-related Liabilities, Current AC3.45
Short-term Debt0.82
Other Liabilities, Current2.05
Total Current Liabilities12.21
Total Long-term Debt0.00
Accounts Payable, Interest-bearing, Noncurrent0.07
Convertible Note Payable Current1.29
Notes Payable Former Officers Current0.00
Total Liabilities12.28
Stockholders' Equity
Common Stock Value0.22
Additional Paid In Capital Common Stock164.13
Retained Earnings / Accumulated Deficit-177.17
Other Equity0.65
Common Stockholder's Equity-12.16
Preferred Stockholder's Equity0.02
Total Stockholder's Equity-12.14
Liabilities & Stockholder's Equity0.14
4 historic quarters locked

Sign in to unlock the full Respirerx Pharmaceuticals Inc balance sheet history.

About Respirerx Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-23-041875

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License